Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.24.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning balance, Shares at May. 31, 2022   359.9      
Beginning balance at May. 31, 2022 $ 3,085.2 $ 3.6 $ 1,545.9 $ 1,669.6 $ (133.9)
Net income 1,206.9     1,206.9  
Unrealized gains (losses) on securities, net of tax expense (benefit) (70.7)       (70.7)
Reclassification adjustment for realized gains (losses) on securities, net of tax expense (benefit) [1] (0.1)       (0.1)
Cash dividends declared (854.5)     (854.5)  
Stock-based compensation costs 46.0   46.0    
Foreign currency translation adjustment 0.5       0.5
Activity related to equity-based plans, Shares   0.6      
Activity related to equity-based plans (12.2) $ 0.0 16.1 (28.3)  
Ending balance, Shares at Feb. 28, 2023   360.5      
Ending balance at Feb. 28, 2023 3,401.1 $ 3.6 1,608.0 1,993.7 (204.2)
Beginning balance, Shares at Nov. 30, 2022   360.5      
Beginning balance at Nov. 30, 2022 3,205.3 $ 3.6 1,588.6 1,811.4 (198.3)
Net income 467.4     467.4  
Unrealized gains (losses) on securities, net of tax expense (benefit) (9.4)       (9.4)
Reclassification adjustment for realized gains (losses) on securities, net of tax expense (benefit) 0.0       0.0
Cash dividends declared (284.9)     (284.9)  
Stock-based compensation costs 16.3   16.3    
Foreign currency translation adjustment 3.5       3.5
Activity related to equity-based plans, Shares   0.0      
Activity related to equity-based plans 2.9 $ 0.0 3.1 (0.2)  
Ending balance, Shares at Feb. 28, 2023   360.5      
Ending balance at Feb. 28, 2023 $ 3,401.1 $ 3.6 1,608.0 1,993.7 (204.2)
Beginning balance, Shares at May. 31, 2023 360.5 360.5      
Beginning balance at May. 31, 2023 $ 3,493.2 $ 3.6 1,626.4 2,023.1 (159.9)
Net income 1,310.5     1,310.5  
Unrealized gains (losses) on securities, net of tax expense (benefit) 9.9       9.9
Reclassification adjustment for realized gains (losses) on securities, net of tax expense (benefit) [1] 0.0       0.0
Cash dividends declared (962.3)     (962.3)  
Repurchases of common shares, Shares [2]   (1.5)      
Repurchases of common shares [2] (169.2) $ 0.0 (6.2) (163.0)  
Stock-based compensation costs 45.1   45.1    
Foreign currency translation adjustment 4.8       4.8
Activity related to equity-based plans, Shares   1.0      
Activity related to equity-based plans $ 15.1 $ 0.0 37.2 (22.1)  
Ending balance, Shares at Feb. 29, 2024 360.0 360.0      
Ending balance at Feb. 29, 2024 $ 3,747.1 $ 3.6 1,702.5 2,186.2 (145.2)
Beginning balance, Shares at Nov. 30, 2023   359.8      
Beginning balance at Nov. 30, 2023 3,524.4 $ 3.6 1,678.6 2,009.4 (167.2)
Net income 498.6     498.6  
Unrealized gains (losses) on securities, net of tax expense (benefit) 19.0       19.0
Reclassification adjustment for realized gains (losses) on securities, net of tax expense (benefit) [1] 0.0       0.0
Cash dividends declared (320.4)     (320.4)  
Repurchases of common shares [2] 0.0 $ 0.0      
Stock-based compensation costs 14.4   14.4    
Foreign currency translation adjustment 3.0       3.0
Activity related to equity-based plans, Shares   0.2      
Activity related to equity-based plans $ 8.1 $ 0.0 9.5 (1.4)  
Ending balance, Shares at Feb. 29, 2024 360.0 360.0      
Ending balance at Feb. 29, 2024 $ 3,747.1 $ 3.6 $ 1,702.5 $ 2,186.2 $ (145.2)
[1] Reclassification adjustments out of accumulated other comprehensive loss for realized gains/(losses), net of tax, on the sale of AFS securities are reflected in interest on funds held for clients and other income, net on the Consolidated Statements of Income and Comprehensive Income.
(2)
The Company maintained a program to repurchase up to $400.0 million of its common stock, with an authorization that expired on January 31, 2024. The purpose of this program is to manage common stock dilution.
[2] The Company maintained a program to repurchase up to $400.0 million of its common stock, with an authorization that expired on January 31, 2024. On January 19, 2024 the Company's Board of Directors approved a new repurchase plan authorizing up to $400.0 million of repurchases of its common stock, with authorization expiring on May 31, 2027. The purpose of these programs is to manage common stock dilution.